As a premier healthcare facility, Greenwich Hospital invests in the most advanced diagnostic and treatment technology available.
Recently, the Greenwich Hospital Auxiliary donated funds to purchase the Hologic Affirm prone biopsy table. This generous gift was received in support of the June Under the Stars fundraiser “Wish List,” a selection of items compiled by physicians and nurses based on their immediate needs.
The Greenwich Hospital Breast Center is grateful for the generosity of the donors who help us continually advance patient care, said Linda LaTrenta, MD, director of Breast Imaging.
This new technology pinpoints breast cancer for early detection and accurate diagnosis. Currently, at least fifty percent of all mammography guided needle biopsies are performed with the Affirm.
Benefits of the Affirm include decreased procedure time, reduction of exposure to radiation, and frequent sparing of surgical biopsy.
It allows us to access abnormalities which are more posterior in the breast, sample lesions which are seen only on tomographic or 3D images, and biopsy faint calcifications which can now be targeted due to the superb image quality produced by the Affirm, said Dr. LaTrenta.
The Breast Center at Smilow Cancer Hospital’s Greenwich Hospital Campus
In 2016, the Breast Center received a three-year, full accreditation by the National Accreditation Program for Breast Centers (NAPBC) for meeting high standards for treating breast disease.
Accreditation by the NAPBC is only given to centers that commit to providing the highest level of quality breast care and undergo a rigorous evaluation and review process. During the survey process, the center must demonstrate compliance with standards established by the NAPBC for treating women who are diagnosed with the full spectrum of breast disease.
As part of the Smilow Cancer Hospital Greenwich Hospital campus, the Breast Center offers state-of-the-art services from detection and treatment through recovery, including three-dimensional mammography, surgical options such as intraoperative radiation therapy, ongoing clinical trials, patient and family support groups, and survivorship programs.